Alena Laschtowitz

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis
  2024 L1 58/100

1 assessed by us (0 reproduced) · 33 not yet assessed — every PubMed paper on record, linked below.

• Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis ↗

  Journal of Hepatology · 2026 · PMID 41864242
  not yet assessed
• Second-line tacrolimus and mycophenolate mofetil in difficult-to-treat autoimmune hepatitis ↗

  Hepatology Communications · 2026 · PMID 41921192
  not yet assessed
• OS-088 Portal endothelial–biliary epithelial crosstalk shapes early primary sclerosing cholangitis ↗

  Journal of Hepatology · 2026
  not yet assessed
• Single-nuclei RNA-sequencing of human liver samples reveals heterogeneity and compositional changes of biliary epithelial cell subpopulations during the progression of primary sclerosing cholangitis ↗

  Zeitschrift für Gastroenterologie · 2025
  not yet assessed
• New treatment targets in autoimmune hepatitis: detection using integrative omics and target validation in a proof of concept phase II clinical trial ↗

  Zeitschrift für Gastroenterologie · 2025
  not yet assessed
• Evaluation of tacrolimus and mycophenolate mofetil as second-line therapy in autoimmune hepatitis – real-world data from the Charité Berlin cohort ↗

  Zeitschrift für Gastroenterologie · 2025
  not yet assessed
• THU-311-YI Uncovering novel therapeutic targets for autoimmune hepatitis (AIH): detection via omics integration and validation in proof-of- concept clinical trial ↗

  Journal of Hepatology · 2025
  not yet assessed
• Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression ↗

  JHEP Reports · 2024 · PMID 39996122
  not yet assessed
• Intergenic risk variant rs56258221 skews the fate of naive CD4+ T cells via miR4464-BACH2 interplay in primary sclerosing cholangitis

  Cell Reports Medicine · 2024 · PMID 38901430
  L1 58/100
• Evaluation von Tacrolimus als Zweitlinientherapie in der Autoimmunen Hepatitis – Real world Daten der Kohorte in der Charité Berlin ↗

  Zeitschrift für Gastroenterologie · 2024
  not yet assessed
• Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression ↗

  International Journal of Molecular Sciences · 2023 · PMID 36982370
  not yet assessed
• Preoperative Immunotherapy in Hepatocellular Carcinoma: Current State of the Art ↗

  Journal of Hepatocellular Carcinoma · 2023 · PMID 36789252
  not yet assessed
• Pathogen detection in RNA-seq data with Pathonoia ↗

  BMC Bioinformatics · 2023 · PMID 36803415
  not yet assessed
• IFNγ and CTLA-4 Drive Hepatic CD4 T-Cell Tolerance and Protection From Autoimmunity in Mice ↗

  Cellular and Molecular Gastroenterology and Hepatology · 2023 · PMID 37734595
  not yet assessed
• Many roads lead to Rome: The FGF4–AMP‐activated protein kinase–Caspase 6 signal axis in NAFLD and NASH ↗

  Hepatology · 2022 · PMID 35278237
  not yet assessed
• Pathogen Detection in RNA-Seq Data with Pathonoia ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2022
  not yet assessed
• Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis ↗

  JHEP Reports · 2021 · PMID 34381983
  not yet assessed
• Genetic aspects of adult and pediatric autoimmune hepatitis: A concise review ↗

  European Journal of Medical Genetics · 2021 · PMID 33812046
  not yet assessed
• Histologische Entzündungsaktivität trotz normwertiger ALT- und IgG-Werte bei Patient*innen mit Autoimmuner Hepatitis und Zirrhose ↗

  Zeitschrift für Gastroenterologie · 2021
  not yet assessed
• Diagnosis and treatment of primary biliary cholangitis ↗

  United European Gastroenterology Journal · 2020 · PMID 32299307
  not yet assessed
• Treatment and re-treatment results of HCV patients in the DAA era ↗

  PLoS ONE · 2020 · PMID 32369527
  not yet assessed
• Systemic CD4 T cell tolerance induction in the liver depends on interferon-γ and CTLA-4 ↗

  Zeitschrift für Gastroenterologie · 2020
  not yet assessed
• Patients with autoimmune hepatitis and liver cirrhosis have disease activity despite normal transaminases ↗

  Journal of Hepatology · 2020
  not yet assessed
• Interferon-gamma and CTLA-4 drive liver-induced systemic CD4 T cell tolerance ↗

  Journal of Hepatology · 2020
  not yet assessed
• Editorial: post‐operative elevation of liver enzymes and modern volatile anaesthetics—guilty as charged? ↗

  Alimentary Pharmacology & Therapeutics · 2019 · PMID 30977179
  not yet assessed
• Krankheitsverständnis und Lebensqualität von Patienten mit chronischer Hepatitis B (HBV) Infektion mit und ohne antivirale Therapie ↗

  Zeitschrift für Gastroenterologie · 2019
  not yet assessed
• Erste Erfahrung mit dem pangenotypischen Therapieregime Glecaprevir/Pibrentasvir (Maviret) zur Behandlung einer chronischen Hepatitis C Infektion ↗

  Zeitschrift für Gastroenterologie · 2019
  not yet assessed
• Signifikante histologische Entzündungsaktivität trotz normwertiger Serum-ALT bei Patienten mit Autoimmuner Hepatitis und Leberzirrhose ↗

  Zeitschrift für Gastroenterologie · 2019
  not yet assessed
• Retherapie von Patienten mit chronischer Hepatitis-C Infektion nach Versagen einer Behandlung mit direct-acting agents (DAA) ↗

  Zeitschrift für Gastroenterologie · 2019
  not yet assessed
• Patienten mit Autoimmuner Hepatitis und Leberzirrhose – Signifikante histologische Entzündungsaktivität trotz biochemischer Remission ↗

  Zeitschrift für Gastroenterologie · 2019
  not yet assessed
• Redundant Tolerance Mechanisms Prevent Autoimmune Liver Inflammation in Mice ↗

  Journal of Hepatology · 2016
  not yet assessed
• Treg impairment is not a sufficient cause of autoimmune liver inflammation ↗

  Zeitschrift für Gastroenterologie · 2015
  not yet assessed
• Redundant tolerance mechanisms prevent autoimmune liver inflammation in mice ↗

  Zeitschrift für Gastroenterologie · 2015
  not yet assessed
• TGF-β-dependent induction of CD4+CD25+Foxp3+ Tregs by liver sinusoidal endothelial cells ↗

  Journal of Hepatology · 2014 · PMID 24798620
  not yet assessed